ADMT vs MDT vs RPM Stock Comparison

Adm Tronics Unlimited, Medtronic and Rpm International Prices as of Oct 29, 2026 Peers: Industry group
MDT Medtronic plc
$97.10 +11.5% 1M +5.9% 1Y
Market cap
$123.68B
P/E
23.6x
Revenue (TTM)
$37.54B
Div. yield
0.03%
Medical Devices Healthcare
7 wins
RPM Rpm International Inc/De/
$102.23 +2.3% 1M -5.7% 1Y
Market cap
$12.91B
P/E
18.7x
Revenue (TTM)
$7.97B
Div. yield
–
Paints and Coatings Basic Materials
3 wins

Head to Head

11 decided of 12

Medtronic leads on 7 of the 12 questions below (Medtronic 7, Rpm International 3, Adm Tronics Unlimited 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionADMTMDTRPMLeader
Larger companyMarket capitalisation $4.06M $123.68B $12.91B MDT
Cheaper on earningsLower P/E, profitable companies only -10.2x 23.6x 18.7x RPM
Cheaper on forward earningsLower price / next fiscal year consensus EPS — 17.4x 18.3x MDT
Faster revenue growthRevenue growth, trailing twelve months -2.2% +9.8% +6.0% MDT
More profitableNet margin, trailing twelve months -12.2% 13.9% 8.7% MDT
Better return on capitalReturn on invested capital -27.1% 6.9% 12.5% RPM
Less leveragedLower net debt / EBITDA -0.9x 2.0x 1.8x ADMT
Higher dividend yieldTrailing dividend yield 0.00% 0.03% 0.00% –
Better 1-year returnPrice return, last 12 months -33.3% +5.9% -5.7% MDT
Better 5-year returnAnnualised price return, 5 years -14.3%/yr -4.1%/yr +3.2%/yr RPM
Less volatileAnnualised volatility, 1 year 185.7% 24.8% 29.8% MDT
Higher overall scoreMean of the five percentile scores vs peers 29/100 66/100 64/100 MDT

Percentile Scorecard

ADMTMDTRPM

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisADMTMDTRPM
Valuation 52 #109 of 227 83 #40 of 227 56 #42 of 94
Growth 2 #213 of 218 52 #105 of 218 66 #32 of 92
Profitability 47 #107 of 202 89 #24 of 202 87 #12 of 86
Financial Health 16 #197 of 233 50 #118 of 233 52 #45 of 93
Shareholder Returns – 58 #55 of 130 57 #31 of 71
Overall 29 66 64
  • ADMT ranked among 247 companies in Medical Devices and Diagnostics
  • MDT ranked among 247 companies in Medical Devices and Diagnostics
  • RPM ranked among 99 companies in Chemicals

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodADMTMDTRPMSPY
1 month +20.0%+11.5%+2.3% +0.7%
3 months +50.0%+13.3%-5.2% +3.7%
6 months -25.0%+19.9%+0.3% +7.1%
Year to date -40.0%+1.1%-1.7% +12.8%
1 year -33.3%+5.9%-5.7% +11.9%
3 years -40.0%+38.8%+12.8% +85.2%
3 years, per year -15.7%+11.5%+4.1% +22.8%
5 years -53.8%-19.0%+17.2% +67.6%
5 years, per year -14.3%-4.1%+3.2% +10.9%
10 years -66.7%+18.5%+114.7% +262.0%
10 years, per year -10.4%+1.7%+7.9% +13.7%

Risk

MeasureADMTMDTRPMSPY
Volatility, 1Y 185.7%24.8%29.8% 12.7%
Downside volatility, 1Y 353.6%22.0%26.2% 12.6%
Beta vs S&P 500, 1Y -1.320.100.94 1.00
Return / volatility, 1Y -0.180.24-0.19 0.94
Max drawdown, 5Y -80.0%-43.6%-33.5% -25.4%
From 52-week high -50.0%-7.8%-14.9% -1.2%
52-week high $0.12$105.35$120.17 $779.14
52-week low $0.03$73.75$93.23 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleADMTMDTRPM
P/E now vs peer median -10.2xmedian 28.7x 23.8xmedian 28.7x 18.8xmedian 21.0x
P/S now vs peer median 1.3xmedian 3.0x 3.3xmedian 3.0x 1.6xmedian 1.4x
EV/EBITDA now vs peer median -16.5xmedian 17.8x 14.8xmedian 17.8x 12.9xmedian 12.9x
P/FCF now vs peer median -25.8xmedian 26.4x 20.3xmedian 26.4x 18.5xmedian 15.5x
P/B now vs peer median 6.7xmedian 2.4x 2.4xmedian 2.4x 3.7xmedian 1.7x
PEG now vs peer median 0.37median 0.99 1.64median 0.99 1.71median 1.68

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsADMTMDTRPM
Revenue $3.24M $37.54B $7.97B
Gross profit $1.27M $24.41B $3.28B
Operating income -$288.99K $6.79B $961.65M
Net income -$395.64K $5.27B $691.27M
Free cash flow -$157.02K $6.13B $705.58M
R&D $522.65K $2.92B –
EPS (diluted) $-0.01 $4.07 $5.42
Cash & equivalents $222.62K $1.69B $312.84M
Total debt $1.93M $113.29B $10.15B
Shares (diluted) 67.59M 1.29B 127.24M
Enterprise value $2.96M $88.93B $11.67B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricADMTMDTRPM
P/E -10.2x 23.8x 18.8x
P/FCF -25.8x 20.3x 18.5x
P/Operating cash flow -25.8x 15.5x 14.1x
P/S 1.3x 3.3x 1.6x
P/B 6.7x 2.4x 3.7x
P/Tangible book 6.8x 3.1x 4.9x
EV/EBITDA -16.5x 14.8x 12.9x
EV/EBIT -14.8x 21.2x 15.7x
EV/Revenue 1.3x 3.8x 1.9x
EV/FCF -27.3x 23.4x 21.4x
EV/Operating cash flow -27.3x 17.9x 16.4x
PEG (3Y EPS CAGR) 0.37 1.64 1.71

Growth

14 metrics
MetricADMTMDTRPM
Revenue growth (1Y) -2.2% 9.8% 6.0%
Revenue CAGR (3Y) -2.7% 6.0% 2.8%
Gross profit growth (1Y) -6.4% 9.3% 5.5%
Gross profit CAGR (3Y) -7.4% 5.6% 5.0%
Operating income growth (1Y) -93.9% 10.9% 9.0%
Operating income CAGR (3Y) -58.3% 6.4% 5.9%
Net income growth (1Y) -485.4% 12.4% 0.2%
Net income CAGR (3Y) -27.7% 13.0% 10.5%
EPS growth (1Y) -485.4% 12.4% 0.8%
EPS CAGR (3Y) -27.7% 14.5% 11.0%
Operating cash flow growth (1Y) -389.0% 12.4% 22.1%
Operating cash flow CAGR (3Y) -84.7% 11.3% 0.4%
Free cash flow growth (1Y) -389.0% 15.6% 36.7%
Free cash flow CAGR (3Y) -84.7% 11.3% 2.0%

Profitability

14 metrics
MetricADMTMDTRPM
Gross margin 39.2% 65.0% 41.2%
EBITDA margin -8.0% 25.9% 14.8%
Operating margin -8.9% 18.1% 12.1%
Pretax margin -12.2% 17.6% 11.4%
Net margin -12.2% 13.9% 8.7%
FCF margin -4.8% 16.3% 8.9%
Operating cash flow margin -4.8% 21.4% 11.6%
Return on equity -67.4% 10.4% 20.4%
Return on assets -20.6% 5.7% 8.3%
Return on invested capital -27.1% 6.9% 12.5%
Return on capital employed -41.9% 8.3% 15.1%
Asset turnover 1.7x 0.4x 1.0x
Cash conversion (OCF / net income) 0.4x 1.5x 1.3x
Stock comp / revenue – 1.3% 0.5%

Financial Health

11 metrics
MetricADMTMDTRPM
Debt / assets 22.2% 30.2% 29.2%
Debt / equity 0.7x 0.6x 0.7x
Net debt / EBITDA -0.9x 2.0x 1.8x
Debt / FCF -2.9x 4.6x 3.4x
Liabilities / assets 70.2% 45.5% 57.7%
Equity / assets 29.8% 54.5% 42.3%
Interest coverage -8.0x 9.4x 8.9x
Current ratio 1.0x 2.1x 1.8x
Quick ratio 0.7x 1.3x 1.0x
Cash ratio 0.2x 0.7x 0.2x
Altman Z-score -20.05 3.06 3.85

Shareholder Returns

7 metrics
MetricADMTMDTRPM
Dividend yield – 2.9% 2.1%
Net buyback yield – 0.2% 0.6%
Shareholder yield – 3.1% 2.8%
Payout ratio (earnings) – 69.3% –
Payout ratio (FCF) – 59.5% –
Dividend growth (1Y) – 1.4% –
Dividend CAGR (3Y) – 0.2% –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusADMTMDTRPM
Forward P/E – 17.4xFY2026 18.3xFY2026
EPS, next fiscal year – $5.57FY2026 $5.58FY2026
EPS growth, next FY – +0.7%FY2026 +0.9%FY2026
EPS growth, the year after – +7.2% +12.5%
Revenue, next fiscal year – $39.92BFY2026 $7.69BFY2026
Revenue growth, next FY – +9.8%FY2026 -2.1%FY2026
Revenue growth, the year after – -4.7% +8.0%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersADMTMDTRPM
Held by institutions – 85.1% 86.1%
Institutions holding – 2,126 796
Change in shares held, QoQ – -0.2% +3.8%
Institutions buying – 1,015 385
Institutions selling – 913 245
Buyers to sellers – 1.11 1.57

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ADMTMDTRPM
ADMT 1.00 0.00 -0.03
MDT 0.00 1.00 0.27
RPM -0.03 0.27 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, ADMT, MDT and RPM?

Medtronic (MDT) is the largest by market capitalisation: Adm Tronics Unlimited (ADMT) $4.06M, Medtronic (MDT) $123.68B, Rpm International (RPM) $12.91B.

Which stock is cheaper, ADMT, MDT and RPM?

Rpm International (RPM) trades on the lowest price-to-earnings ratio (Adm Tronics Unlimited (ADMT) -10.2x, Medtronic (MDT) 23.6x, Rpm International (RPM) 18.7x). On next year's consensus earnings, Medtronic (MDT) is cheapest (Medtronic (MDT) 17.4x, Rpm International (RPM) 18.3x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Medtronic (MDT) grew revenue fastest over the trailing twelve months: Adm Tronics Unlimited (ADMT) -2.2%, Medtronic (MDT) +9.8%, Rpm International (RPM) +6.0%.

Which company is more profitable?

Medtronic (MDT) has the highest net margin (Adm Tronics Unlimited (ADMT) -12.2%, Medtronic (MDT) 13.9%, Rpm International (RPM) 8.7%). On return on invested capital, Rpm International (RPM) leads (Adm Tronics Unlimited (ADMT) -27.1%, Medtronic (MDT) 6.9%, Rpm International (RPM) 12.5%).

Which stock has performed better?

Over the past year Medtronic (MDT) returned the most: Adm Tronics Unlimited (ADMT) -33.3%, Medtronic (MDT) +5.9%, Rpm International (RPM) -5.7%. Over five years, Rpm International (RPM) compounded fastest (Adm Tronics Unlimited (ADMT) -14.3%/yr, Medtronic (MDT) -4.1%/yr, Rpm International (RPM) +3.2%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Adm Tronics Unlimited (ADMT) 0.00%, Medtronic (MDT) 0.03%, Rpm International (RPM) 0.00%. Adm Tronics Unlimited (ADMT) and Rpm International (RPM) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Medtronic (MDT) has been the steadiest (Adm Tronics Unlimited (ADMT) 185.7%, Medtronic (MDT) 24.8%, Rpm International (RPM) 29.8%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, ADMT, MDT and RPM?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Medtronic (MDT) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.